• Aucun résultat trouvé

HORUSPHARMA Aires-

N/A
N/A
Protected

Academic year: 2022

Partager "HORUSPHARMA Aires-"

Copied!
2
0
0

Texte intégral

(1)

Agence nationale de securite du medicament et des produits de sante (ANSM) 143/147, boulevard Anatole France

FR-93285 SAINT-DENIS CEDEX France

Buenos Aires, September 191\ 2016

LETTER OF ACCESS TO OUR EUROPEAN DMF FOR TRA VOPROST (Internal DMF reference number TV/05/2015-07)

National Reference Number 2014-148

Number of Active Substance Master File: Travoprost TV /05/2015/07

Manufacturing site:

Delta Biotech

S.A. -Armenia 3881, Munro, Vicente Lopez - Pcia. Buenos Aires - Argentina

Active Substance Master File holder:

Delta Biotech S.A.

- Armenia 3881, Munro, Vicente Lopez - Pcia. Buenos Aires- Argentina

The aforementioned Active Substance Master File holder hereby authorizes the ANSM, to refer to and review the above mentioned Active Substance Master File in support of the following Marketing Authorization Application submitted by Horus Pharma for:

Travoprost-Timolol Horus Pharma 40micrograms/mL+5mg/mL

DC: DK/H/2708/00 1/DC

MA number:-

HORUSPHARMA

148 A venue Georges Guynemer Cap Var D2

06700 Saint Laurent du Var France

(2)

AEMPS

Agencia Espanola de Medicamentos y Productos Sanitarios Parque Empresarial Las Mercedes

C/ Campezo 28022 Madrid

SPAIN

10 ..

Buenos Aires, september 19th, 2016 '

LETTER OF ACCESS TO OUR EUROPEAN DMF FOR TRA YO PROST (Internal DMF reference number TV/05/2015-07)

National Reference Number 09/01/2015 AA/0004/ 15

Number of Active Substance Master File: Travoprost TV /05/2015/07

Manufacturing site: Delta Biotech S.A.- Armenia 3881, Munro, Vicente Lopez- Pcia. Buenos Aires- Argentina

Active Substance Master File holder: Delta Biotech S.A.- Armenia 3881, Munro, Vicente Lopez - Pcia. Buenos Aires - Argentina

The aforementioned Active Substance Master File holder hereby authorizes the Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS), to refer to and review the above mentioned Active Substance Master File in support of the following Marketing Authorization Application submitted by Horus Pharma for:

Travoprost-Timolol Horus Pharma 40micrograms/mL+5mg/mL

DC: DK/H/2708/001/DC

MA number:-

HORUS PHARMA

148 A venue Georges Guynemer Cap Var D2

06700 Saint Laurent du Var France

Delta J3iotech S.A.

Armenia 3881- (B1605CE1)- munro Pcia. de Buenos A1res - Argentina Tei./Fax: (5411) 4700-8025 (rotativas ) info@deltabiotech. com. ar - www .deltabiotech. com .ar

Références

Documents relatifs

The End-of-File control word causes input processing to revert to the file that invoked, the current imbed file.. If the current file was not imbedded,

The af orementioned Active Substance Master File holder hereby authorizes the ANSM, to refer to and review the above mentioned Active Substance Master File in

Foundation grants are calculated under formulae devised under this system and the grants are then paid to the school divisions in Manitoba through the agency of the Public

We  reviewed  the  full  texts  and  abstracts  of  150  arti- cles  to  isolate  those  34  articles  relating  to  alcohol  and  drug 

Although the protocol does not restrict closing or leaving open the data connection in Block and Text modes, it should be emphasized that the closing of the data

In effect, FTP provides means for a user to have (parts of) file activity of the sort typically initiated at the command language level.. "slaved" across

Consequently, a SIP REFER-Issuer generating a REFER request with multiple REFER-Targets SHOULD include the "norefersub" option-tag in a Require header field and

For example, in the case of IPv6 implementations that have been updated to support [RFC5722], if a fragment with the same {IPv6 Source Address, IPv6 Destination